Small Cap Unusual Volume: DuPont Fabros Technology (NYSE:DFT),Steel Partners Holdings (NYSE:SPLP), Clifton Savings Bancorp (NASDAQ:CSBK), Amyris Inc (NASDAQ:AMRS)

DuPont Fabros Technology, Inc. (NYSE:DFT) announced that the Company will release its first quarter 2014 operating results on Thursday, April 24, 2014 before the market opens and host a conference call on the same day at 1:00 p.m. ET to discuss those results. DuPont Fabros Technology, Inc. (NYSE:DFT) shares after opening at $22.94 moved to $ 24.17on last trade day and at the end of the day closed at $23.82. Company price to sales ratio in past twelve months was calculated as 5.16and price to cash ratio as 50.06. DuPont Fabros Technology, Inc. (NYSE:DFT) showed a negative weekly performance of -0.50%.

Steel Partners Holdings L.P (NYSE:SPLP) a global diversified holding company, today announced that its Board of Directors has authorized a modified “Dutch Auction” tender offer (the “Offer”) to purchase for cash up to $49 million in value of its common units, no par value, at a price per unit of not less than $16.50 nor greater than $17.50 per unit. Steel Partners Holdings LP (NYSE:SPLP) shares fell -1.29% in last trading session and ended the day on $16.77. SPLP return on equity ratio is recorded as -1.60% and its return on assets is -0.60%. Steel Partners Holdings LP (NYSE:SPLP) yearly performance is 25.24%.

Clifton Savings Bancorp (NASDAQ:CSBK) SVP Francis Tracy Tripucka bought 10,000 shares of Clifton Savings Bancorp stock in a transaction that occurred on Tuesday, April 1st. The shares were purchased at an average cost of $10.00 per share, with a total value of $100,000.00. Clifton Savings Bancorp, Inc. (NASDAQ:CSBK) shares moved up 1.38% in last trading session and was closed at $11.77 while trading in range of $11.46 – $11.83 – Clifton Savings Bancorp, Inc. (NASDAQ:CSBK) year to date (YTD) performance is -9.95%.

Amyris Inc (NASDAQ:AMRS)’s on Apr. 3 announced that it is entering into a collaborative research and development agreement with BASF SE (BAS.DE). Under the agreement, Amyris will use its strain engineering technology to develop a microorganism capable of producing a target molecule identified by BASF. Amyris Inc (NASDAQ:AMRS) weekly performance is 3.33%. On last trading day company shares ended up $4.19. Amyris Inc (NASDAQ:AMRS) distance from 50-day simple moving average (SMA50) is 3.03%. Analysts mean target price for the company is $8.55.